Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × pembrolizumab × CNS × Clear all

Status

Sponsor Class

Study Type

Interventional 74 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Thoracic 15 Dermatologic 10 Head & Neck 6 Genitourinary 5 Gastrointestinal 5 Breast 2 Tumor-Agnostic 1 Other 1 CNS 1

Conditions

Brain Neoplasms 1

Interventions

Surveys and Questionnaires 20 Radiotherapy 20 Magnetic Resonance Spectroscopy 19 Blood Specimen Collection 18 Radiosurgery 15 Magnetic Resonance Imaging 12 Temozolomide 10 Surgical Procedures, Operative 10 Neuropsychological Tests 10 Radiation 7 Polymerase Chain Reaction 7 Immunohistochemistry 7 Amplified Fragment Length Polymorphism Analysis 7 Gene Expression Profiling 6 Phlebotomy 5 Observation 5 Flow Cytometry 5 Microarray Analysis 4 Interviews as Topic 4 Biopsy 4 gadobenic acid 3 Transurethral Resection of Bladder 3 Radiotherapy, Intensity-Modulated 3 Quality of Life 3 Perfusion Magnetic Resonance Imaging 3 Mental Status and Dementia Tests 3 In Situ Hybridization, Fluorescence 3 Genetic Testing 3 Diffusion Tensor Imaging 3 Diagnostic Imaging 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03458455 2023-11-01

TREATMENT

Oslo University Hospital

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡